Complete Genomics Inc, a complete human genome sequencing company, introduces a new cancer grant program. Winning research applications will receive complete human genome sequencing of eight genomes—four tumor/normal pairs. Four winning entries will be chosen: two each from the US and Europe.
Complete Genomics is accepting grant applications for cancer-specific research projects using its complete human genome sequencing service from now until July 29, 2011. Applications will be evaluated by an internal panel of scientific experts at Complete Genomics. Winners will be notified by August 12 and will be required to submit their samples by September 16. In addition, all applicants will be automatically eligible for a discount on their next complete human genome sequencing project.
“We designed this grant program to recognize and reward those scientists who are developing innovative cancer research projects,” said Clifford Reid, chairman, president and CEO of Complete Genomics. “We are delighted to have the opportunity to provide pioneering scientists with complete human genome sequencing and research-ready data that they can immediately use to gain insights into the characterization and possible treatment of various cancers.”
For more information about the grant program or to submit an application, [removed]click here[/removed].
Source: Complete Genomics Inc
